Reversible competitive inhibitors, such as edrophonium, physostigmine, and neostigmine, are used in the treatment of myasthenia gravis[96] and in anaesthesia to reverse muscle blockade.
Domain | tacc3receptor.com |
---|---|
Homepage URL | https://tacc3receptor.com/index.php/another-occasion-outlook-during-secondary-school-students-school/ |
Keywords | small molecules phosphatase inhibitors signaling pathway |
Sprache | englisch |